CTCM Congress 2012: Human bounded research

The CTCM (Clinical Trial Center Maastricht) and the MUMC+ (Maastricht Universitair Medisch Centrum) organise a conference on the future of human bounded research on the 26th of January 2012.

The Clinical Trial Center Maastricht supports the researchers in the MUMC+ on every aspect of clinical research since it’s founding in 2005.

For this conference all stakeholders of human bounded research at the MUMC+ are invited and also representatives from the (pharma) industry and representatives from the life science companies in the MUMC+ environment.

During the conference the future developments will be discussed regarding human bounded research. The speakers will talk about research in the near future from different views;
-    From the industry (Director Quintiles Netherlands)
-    From the allowance provider (Programme leader zonMW)
-    From the Government (Inspector IGZ and general secretary CCMO)
-    MUMC+

After the presentations a panel discussion will take place, where next to the speakers, several prominent researchers from the MUMC+ will discuss the future of human bounded research. The moderator, Prof Herman Pieterse, Profess Medical Consultancy BV, authority in the field of GCP in the Netherlands, will lead the discussion. Thanks to his experience and critical look, it promises to be a very interesting discussion.

Speakers;
Drs. G. Peeters - RvB MUMC+
Dr. S.J. de Visser – ZonMw
Dhr. H. Kamsteeg – Quintiles
Dr. M. Kenter - CCMO
Dr. ir. J. Eland Gerritsen - Inspectie IGZ 
Prof. dr. H. Pieterse - Profess B.V.